IP Library Granted Patent US 9,801,660
Granted Patent B2
US 9,801,660 · App. 14/448,087 · Granted Oct 31, 2017

Implantable fluid delivery devices, systems, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,801,660
App. No.
14/448,087
Granted
Oct 31, 2017
Kind
B2
Abstract

Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.

Claims (29)

1. An implantable fluid delivery device, comprising:

a housing configured for intravaginal deployment and retention in a subject;

at least one reservoir associated with the housing and configured to contain a fluid; and

a fluid dispensing mechanism disposed within the housing and configured to dispense the fluid from the at least one reservoir past the cervix and to the uterus of the subject,

wherein the device is configured to dispense the fluid when an estrus condition of the subject detected by the device meets a predetermined threshold,

wherein the at least one reservoir comprises a tube extending from a gas reservoir of the device, the tube comprising at least one gas chamber configured to (i) receive gas from the gas reservoir, (ii) inflate the tube, and (iii) urge the tube into an extended position, and

wherein the at least one gas chamber of the tube is in fluid communication with the fluid contained in the tube such that when the gas chamber inflates, the fluid is driven out of the tube.

2. The device of claim 1 , wherein the tube is sized to extend past the cervix of the subject in the extended position.

3. The device of claim 1 , wherein:

the tube is configured to have a coiled unstressed position, and

the extended position is an uncoiled position.

4. The device of claim 1 , wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.

5. A method of delivering fluid to a subject, comprising:

intravaginally deploying and retaining a device in the subject, the device comprising at least one reservoir containing a fluid and a fluid dispensing mechanism; and

dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject, wherein the dispensing occurs after an estrus condition of the subject detected by the device meets a predetermined threshold,

wherein the at least one reservoir comprises a tube extending from a gas reservoir of the device, the tube comprising at least one gas chamber, which is in fluid communication with the fluid contained in the tube, and

wherein dispensing the fluid from the device comprises inflating the at least one gas chamber of the tube with gas from a gas reservoir of the device, thereby urging the tube into an extended position and driving the fluid from the tube.

6. The method of claim 5 , wherein the tube is sized to extend past the cervix of the subject in the extended position.

7. The method of claim 5 , wherein

the tube is configured to have a coiled unstressed position, and

the extended position is an uncoiled position.

8. The method of claim 5 , wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.

9. An implantable fluid delivery device, comprising:

a housing configured for intravaginal deployment and retention in a subject;

at least one reservoir associated with the housing and configured to contain a fluid; and

a fluid dispensing mechanism disposed within the housing and configured to dispense the fluid from the at least one reservoir past the cervix and to the uterus of the subject,

wherein the at least one reservoir comprises a tube extending from a gas reservoir of the device, the tube comprising at least one gas chamber configured to (i) receive gas from the gas reservoir, (ii) inflate the tube, and (iii) urge the tube into an extended position,

wherein the at least one gas chamber of the tube is in fluid communication with the fluid contained in the tube such that when the gas chamber inflates, the fluid is driven out of the tube, and

wherein the fluid comprises a drug, semen, ova, or a combination thereof.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →